All In MedTech

Device Trial Radar · NCT04607746

Pivotal Study of the CapsoCam Colon (CV-3) in Detecting Colonic Polyps, Using Colonoscopy as the Reference

Prospective Open Label, Pivotal Study of the Accuracy of The CapsoCam Colon (CV-3) in Detecting Colonic Polyps, Using Colonoscopy as the Reference

Last checked: Nov 19, 2026Latest source record: Jul 8, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingTitle says "pivotal". This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,337

Actual

Start

Jan 6, 2021

Primary completion

Feb 14, 2025

Study completion Feb 14, 2025

Sponsor

Lead sponsor
Capso Vision, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Oct 29, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
Yes
Who can join
All sexes, from 45 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the safety and effectiveness of the CapsoCam Colon (CV-3) endoscope system for the detection of colonic polyps.

Conditions

  • Colonic Polyp

Interventions

  • Capsule EndoscopeDevice

    Capsule endoscope used to view colonic mucosa

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Positive Percent Agreement/Negative Percent AgreementTime frame: 6 weeks

Locations

23 sites in 1 country. Site status is shown where the registry gives one.

  • Mayo Clinic

    Scottsdale, Arizona

  • Gastro Care Institute

    Lancaster, California

  • inSite Digestive Health Care

    Los Gatos, California

20 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.